INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,301,801 | +14.0% | 487,200 | -4.7% | 0.02% | +23.1% |
| Q2 2023 | $10,788,389 | +50.2% | 511,298 | +21.4% | 0.01% | +44.4% |
| Q1 2023 | $7,181,937 | +26.2% | 421,228 | +47.9% | 0.01% | +12.5% |
| Q4 2022 | $5,691,682 | -24.0% | 284,869 | -18.0% | 0.01% | -27.3% |
| Q3 2022 | $7,487,023 | +133.7% | 347,587 | +113.9% | 0.01% | +37.5% |
| Q2 2022 | $3,204,000 | +195.0% | 162,487 | +251.5% | 0.01% | +300.0% |
| Q1 2022 | $1,086,000 | -75.0% | 46,232 | -71.0% | 0.00% | -75.0% |
| Q4 2021 | $4,344,000 | -46.8% | 159,476 | -46.2% | 0.01% | -50.0% |
| Q3 2021 | $8,163,000 | -20.0% | 296,417 | -17.3% | 0.02% | -20.0% |
| Q2 2021 | $10,199,000 | +85.1% | 358,372 | +121.5% | 0.02% | +81.8% |
| Q1 2021 | $5,511,000 | -8.9% | 161,820 | -11.0% | 0.01% | -8.3% |
| Q4 2020 | $6,050,000 | -60.0% | 181,732 | -61.4% | 0.01% | -63.6% |
| Q3 2020 | $15,118,000 | +17.2% | 470,389 | +0.4% | 0.03% | +10.0% |
| Q2 2020 | $12,902,000 | +48.7% | 468,482 | -13.5% | 0.03% | +30.4% |
| Q1 2020 | $8,677,000 | -29.8% | 541,322 | +4.6% | 0.02% | -11.5% |
| Q4 2019 | $12,364,000 | +10.3% | 517,723 | -18.5% | 0.03% | +4.0% |
| Q3 2019 | $11,212,000 | -18.6% | 635,606 | +18.1% | 0.02% | -16.7% |
| Q2 2019 | $13,774,000 | +13.0% | 538,040 | +28.4% | 0.03% | +11.1% |
| Q1 2019 | $12,186,000 | -26.6% | 419,182 | -66.9% | 0.03% | -34.1% |
| Q4 2018 | $16,606,000 | -29.4% | 1,265,677 | +8.8% | 0.04% | -14.6% |
| Q3 2018 | $23,517,000 | -5.6% | 1,163,027 | +10.4% | 0.05% | -9.4% |
| Q2 2018 | $24,914,000 | +38.5% | 1,053,468 | +31.9% | 0.05% | +39.5% |
| Q1 2018 | $17,985,000 | -15.6% | 798,615 | +16.9% | 0.04% | -13.6% |
| Q4 2017 | $21,300,000 | +1866.8% | 683,139 | +1867.8% | 0.04% | +2100.0% |
| Q3 2017 | $1,083,000 | +125.6% | 34,716 | +24.2% | 0.00% | +100.0% |
| Q2 2017 | $480,000 | +7.1% | 27,960 | +9.3% | 0.00% | 0.0% |
| Q1 2017 | $448,000 | +32.5% | 25,571 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $338,000 | -8.9% | 25,571 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $371,000 | +47.2% | 25,571 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $252,000 | -22.2% | 25,571 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $324,000 | -30.2% | 25,571 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $464,000 | -2.3% | 25,571 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $475,000 | -31.6% | 25,571 | -10.1% | 0.00% | -50.0% |
| Q2 2015 | $694,000 | +23.7% | 28,439 | +5.5% | 0.00% | +100.0% |
| Q1 2015 | $561,000 | +34.5% | 26,956 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $417,000 | +18.5% | 26,956 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $352,000 | -34.7% | 26,956 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $539,000 | +5.1% | 26,956 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $513,000 | +11.8% | 26,956 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $459,000 | +38.7% | 26,956 | +27.3% | 0.00% | 0.0% |
| Q3 2013 | $331,000 | +30.8% | 21,174 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $253,000 | – | 21,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |